Short answer
Zenas BioPharma, Inc. (ZBIO) filed an 8-K current report with the SEC on March 16, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q4 and full-year 2025 financial results announced March 16, 2026.
Zenas BioPharma, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q4 and full-year 2025 financial results announced March 16, 2026
- Actual figures in Exhibit 99.1 press release: key metrics not detailed in this filing item
- "Furnished" (not "filed") status limits legal liability under Exchange Act Section 18
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Zenas BioPharma, Inc. 8-K filings
Get the next ZBIO 8-K as it lands
Follow ZBIO for push alerts, or ask the research agent what this filing means.